---
title: "Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, GMP-ready platform"
description: Insights into Cellistic's NK manufacturing solution, the Echo™-NK platform, highlighting its innovative technologies and processes
---

[Expert Insights ](https://www.cellistic.com/insights)

# [Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, GMP-ready platform](https://www.cellistic.com/insights/scaling-nk-cell-manufacturing-from-ipscs-to-nk-cells-in-a-feeder-free-gmp-ready-platform)

 Written by [cellistic](https://www.cellistic.com/insights/author/cellistic) | Apr 16, 2025 11:49:47 AM

Natural Killer (NK) cell treatments are not readily accessible to patients due to persistent manufacturing complexities, scalability issues, and challenges in delivery. Cellistic's iPSC-based allogeneic Echo™-NK Manufacturing Platform breaks down these barriers by enabling therapeutic developers to manufacture safe, consistent, and cost-efficient off-the-shelf NK cell therapies at scale.

In her latest article, Anne-Sophie Lebrun, MSAT Director, provides an in-depth look at the Echo™-NK platform's comprehensive manufacturing process, specifically designed to tackle the scientific and logistical challenges that impede NK cell therapies with a cost effective approach.

##### Highlights of the insights include:

- Unit Operations Overview: A detailed look at the Unit Operations (UOP) from GMP Master Cell Bank to final drug product release, highlighting volume expansion capabilities and the specific technologies utilized at each step.
- Innovative Features and Technologies: An exploration of key innovations, including a feeder-free culture system that enhances both safety and consistency, as well as advanced bioreactor technologies that ensure compliance with GMP standards.
- Compliance and Proven Performance: Insight into critical performance metrics and results that validate the efficacy and reliability of the Echo™-NK platform, underscoring its potential as a commercially viable solution for NK cell therapy manufacturing.

#### Get all the technical details—download the article to enhance your understanding of the Echo™-NK platform!

[View full post](https://www.cellistic.com/insights/scaling-nk-cell-manufacturing-from-ipscs-to-nk-cells-in-a-feeder-free-gmp-ready-platform)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "cellistic"
  },
  "dateModified" : "2026-03-16T10:47:38.380Z",
  "datePublished" : "2025-04-16T11:49:47Z",
  "headline" : "Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, GMP-ready platform",
  "image" : {
    "@type" : "ImageObject",
    "height" : 675,
    "url" : "https://21588612.fs1.hubspotusercontent-na1.net/hubfs/21588612/Cellistic%20blog_Features%20im_Technical%20insights%20%281%29.png",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://www.cellistic.com/insights/scaling-nk-cell-manufacturing-from-ipscs-to-nk-cells-in-a-feeder-free-gmp-ready-platform",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://21588612.fs1.hubspotusercontent-na1.net/hubfs/21588612/Cellistic_June2022/images/header-logo.png",
      "width" : 245.10638
    },
    "name" : "Expert Insights from Cellistic"
  }
}
```